Company: BDRX
Filing Date: 2025-01-28
Form Type: 424B3
Source: 0001214659-25-001409
Chunk: 409

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-28
Form: 424B3
Chunk 409
---
98,000)

| F-71 |

| 24 | Share-based payments |

Share Options

The Group has issued
options over ordinary shares under the 2014 Biodexa Pharmaceuticals PLC Enterprise Management Incentive Scheme and unapproved share options
awarded to non-UK staff. In addition, certain share options originally issued over shares in Biodexa Limited under the Biodexa Limited
2008 unapproved share option scheme or Biodexa Limited 2013 approved Enterprise Incentive scheme were reissued in 2015 over shares in
Biodexa Pharmaceuticals PLC under the 2014 Biodexa Pharmaceuticals PLC Enterprise Management Incentive Scheme. Exercise of an option is
subject to continued employment.

At a General Meeting
on 24 March 2023, shareholders approved a consolidation of the Company’s Ordinary Shares on a one for 20 basis. As a result, the
par value of the Ordinary Shares was changed from £0.001 per share to £0.02 per share.

At a General Meeting
on 14 June 2023, shareholders approved the subdivision and redesignation of the Company’s Issued Ordinary Shares of £0.02
each into to one Ordinary Share of £0.001 each and 19 ‘B’ Deferred Shares of £0.001 each.

The options granted
in 2023 were made under the 2014 Biodexa Pharmaceuticals PLC Enterprise Management Incentive Scheme.

Details of all share
options granted under the Schemes are set out below:

| Details of all share options granted under the Schemes are set out below:              |     |              |     |                 |     |                |   |     |              |   |     |          |     |   |                 |
| Date of grant                                                                          |     | At 1 January 
         2023 |     | Granted in 2023 |     | Lapsed in 2023 |   |     | Forfeited in 
 2023         |   |     |   At  31 
 December 
     2023 |     |   | Exercise  Price |
| 30 June 2014                                                                           |     |           25 |     | –               |     | –              |   |     | –            |   |     |       25 |     | £ |           30.00 |
| 19 December 2016                                                                       |     |           13 |     | –               |     | –